- Home
- DXCM vs IDXX Comparison
DXCM vs IDXX Comparison
Compare DXCM & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- IDXX
- Stock Information
- Founded
- DXCM 1999
- IDXX 1983
- Country
- DXCM United States
- IDXX United States
- Employees
- DXCM N/A
- IDXX N/A
- Industry
- DXCM Medical/Dental Instruments
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DXCM Health Care
- IDXX Health Care
- Exchange
- DXCM Nasdaq
- IDXX Nasdaq
- Market Cap
- DXCM 34.1B
- IDXX 37.9B
- IPO Year
- DXCM 2005
- IDXX 1991
- Fundamental
- Price
- DXCM $80.75
- IDXX $520.24
- Analyst Decision
- DXCM Strong Buy
- IDXX Buy
- Analyst Count
- DXCM 20
- IDXX 8
- Target Price
- DXCM $98.50
- IDXX $546.00
- AVG Volume (30 Days)
- DXCM 2.8M
- IDXX 499.3K
- Earning Date
- DXCM 07-24-2025
- IDXX 08-05-2025
- Dividend Yield
- DXCM N/A
- IDXX N/A
- EPS Growth
- DXCM N/A
- IDXX 4.80
- EPS
- DXCM 1.33
- IDXX 10.82
- Revenue
- DXCM $4,148,000,000.00
- IDXX $3,931,836,000.00
- Revenue This Year
- DXCM $16.74
- IDXX $8.17
- Revenue Next Year
- DXCM $15.27
- IDXX $7.64
- P/E Ratio
- DXCM $60.81
- IDXX $48.07
- Revenue Growth
- DXCM 9.11
- IDXX 5.56
- 52 Week Low
- DXCM $57.52
- IDXX $356.14
- 52 Week High
- DXCM $117.49
- IDXX $530.73
- Technical
- Relative Strength Index (RSI)
- DXCM 43.91
- IDXX 57.69
- Support Level
- DXCM $80.23
- IDXX $513.92
- Resistance Level
- DXCM $83.70
- IDXX $530.12
- Average True Range (ATR)
- DXCM 1.88
- IDXX 8.81
- MACD
- DXCM -0.90
- IDXX -2.86
- Stochastic Oscillator
- DXCM 12.63
- IDXX 58.43
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.